Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Headache, Lymphadenopathy
Clinical narrative: I developed a fever that peaked out at 101.5; muscle and joint aches; muscle and joint aches; headache; swelling of left armpit lymph node; serious hives on my feet, hands, torso, and face; I also had extreme fatigue.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Jul2022 at 13:00 as dose 4 (booster), single (Lot number: FP7139) at the age of 53 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "hypertension" (unspecified if ongoing); "environmental allergies" (unspecified if ongoing); "sulfa antibiotics" (unspecified if ongoing); "Known Allergies: mold" (unspecified if ongoing), notes: Known Allergies: codiene, sulfa antibiotics, mold, pollen, peanuts, carrots and celery; "Known Allergies: pollen" (unspecified if ongoing), notes: Known Allergies: codiene, sulfa antibiotics, mold, pollen, peanuts, carrots and celery; "Known Allergies: peanuts" (unspecified if ongoing), notes: Known Allergies: codiene, sulfa antibiotics, mold, pollen, peanuts, carrots and celery; "Known Allergies: carrots and celery" (unspecified if ongoing), notes: Known Allergies: codiene, sulfa antibiotics, mold, pollen, peanuts, carrots and celery. Concomitant medication(s) included: METOPROLOL; MONTELUKAST; LORATADINE; VITAMIN D [VITAMIN D NOS]. Past drug history included: Codiene, reaction(s): "known allergies: codiene". Vaccination history included: Covid-19 vaccine (Dose 3, Manufacturer Unknown), for Covid-19 Immunization; Covid-19 vaccine (Dose 2, Manufacturer Unknown), for Covid-19 Immunization; Covid-19 vaccine (Dose 1, Manufacturer Unknown), for Covid-19 Immunization. The following information was reported: FATIGUE (non-serious) with onset 14Jul2022 at 09:00, outcome "recovered", described as "I also had extreme fatigue."; PYREXIA (non-serious) with onset 14Jul2022 at 09:00, outcome "recovered" (Jul2022), described as "I developed a fever that peaked out at 101.5"; HEADACHE (non-serious) with onset 14Jul2022 at 09:00, outcome "recovered" (Jul2022); MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 14Jul2022 at 09:00, outcome "recovered" (Jul2022) and all described as "muscle and joint aches"; URTICARIA (non-serious) with onset 14Jul2022 at 09:00, outcome "recovered" (Jul2022), described as "serious hives on my feet, hands, torso, and face"; LYMPHADENOPATHY (non-serious) with onset 14Jul2022 at 09:00, outcome "recovered" (Jul2022), described as "swelling of left armpit lymph node". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, myalgia, arthralgia, headache, lymphadenopathy, urticaria, fatigue.  Additional information: It was reported that the day after the vaccine, patient developed a fever that peaked out at 101.5, muscle and joint aches, headache, swelling of left armpit lymph node, and serious hives on my feet, hands, torso, and face. It took a couple days for everything to subside. Patient also had extreme fatigue. Patient had no covid prior vaccination and was not tested covid Post vaccination. No other other vaccine in four weeks.   No follow-up attempts are possible. No further information is expected.